Bloomage BioTechnology Corporation Limited (SHA:688363)
China · Delayed Price · Currency is CNY 59.11
-0.40 (-0.67%)
Sep 12, 2025, 3:00 PM CST
SHA:688363 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 4,819 | 5,361 | 6,075 | 6,359 | 4,947 | 2,632 | Upgrade |
Other Revenue | 1.94 | 9.49 | 0.6 | 0.41 | 0.55 | 1.05 | Upgrade |
| 4,821 | 5,371 | 6,076 | 6,359 | 4,948 | 2,633 | Upgrade | |
Revenue Growth (YoY) | -17.04% | -11.61% | -4.45% | 28.53% | 87.93% | 39.63% | Upgrade |
Cost of Revenue | 1,440 | 1,482 | 1,659 | 1,482 | 1,118 | 510.98 | Upgrade |
Gross Profit | 3,381 | 3,889 | 4,417 | 4,877 | 3,829 | 2,122 | Upgrade |
Selling, General & Admin | 2,777 | 3,118 | 3,331 | 3,439 | 2,736 | 1,256 | Upgrade |
Research & Development | 496.83 | 466.25 | 446.35 | 388.19 | 284.34 | 141.16 | Upgrade |
Other Operating Expenses | 68.59 | 46.48 | 62.01 | 73.25 | 56.95 | 30.45 | Upgrade |
Operating Expenses | 3,368 | 3,656 | 3,847 | 3,915 | 3,083 | 1,452 | Upgrade |
Operating Income | 13.08 | 232.36 | 570.18 | 961.48 | 746.46 | 670.05 | Upgrade |
Interest Expense | -7.79 | -9.17 | -10.74 | -14.52 | -11.08 | - | Upgrade |
Interest & Investment Income | 7.83 | 14.11 | 39.78 | 50.44 | 45.07 | 52.19 | Upgrade |
Currency Exchange Gain (Loss) | 15.35 | 2.97 | 3.9 | 25.19 | -12.05 | -16.99 | Upgrade |
Other Non Operating Income (Expenses) | -1.31 | -4.76 | 1.71 | -3.88 | -2.62 | -0.77 | Upgrade |
EBT Excluding Unusual Items | 27.16 | 235.51 | 604.84 | 1,019 | 765.77 | 704.49 | Upgrade |
Impairment of Goodwill | -74.09 | -74.09 | - | - | - | - | Upgrade |
Gain (Loss) on Sale of Investments | -13.67 | -11.48 | -18.74 | -0.14 | 7.39 | 3.34 | Upgrade |
Gain (Loss) on Sale of Assets | -1.42 | -0.11 | -3.42 | -0.24 | 0.04 | 0.05 | Upgrade |
Asset Writedown | -0.86 | -0.86 | -1.87 | -0.53 | -3.91 | -0.34 | Upgrade |
Other Unusual Items | 119.18 | 64.43 | 120.91 | 118.32 | 120.9 | 51.36 | Upgrade |
Pretax Income | 56.31 | 213.39 | 701.72 | 1,136 | 890.2 | 758.9 | Upgrade |
Income Tax Expense | 7.6 | 44.99 | 118.98 | 174.73 | 114.64 | 113.89 | Upgrade |
Earnings From Continuing Operations | 48.71 | 168.41 | 582.74 | 961.38 | 775.56 | 645.01 | Upgrade |
Minority Interest in Earnings | 4.65 | 5.86 | 9.81 | 9.54 | 6.78 | 0.83 | Upgrade |
Net Income | 53.35 | 174.27 | 592.56 | 970.92 | 782.33 | 645.84 | Upgrade |
Net Income to Common | 53.35 | 174.27 | 592.56 | 970.92 | 782.33 | 645.84 | Upgrade |
Net Income Growth | -89.53% | -70.59% | -38.97% | 24.10% | 21.14% | 10.29% | Upgrade |
Shares Outstanding (Basic) | 483 | 484 | 482 | 481 | 480 | 478 | Upgrade |
Shares Outstanding (Diluted) | 483 | 484 | 482 | 483 | 483 | 478 | Upgrade |
Shares Change (YoY) | 0.47% | 0.48% | -0.27% | 0.03% | 0.95% | 9.47% | Upgrade |
EPS (Basic) | 0.11 | 0.36 | 1.23 | 2.02 | 1.63 | 1.35 | Upgrade |
EPS (Diluted) | 0.11 | 0.36 | 1.23 | 2.01 | 1.62 | 1.35 | Upgrade |
EPS Growth | -89.58% | -70.73% | -38.81% | 24.07% | 20.00% | 0.75% | Upgrade |
Free Cash Flow | 103.02 | -156.88 | -330.68 | -61.22 | 491.85 | -57.65 | Upgrade |
Free Cash Flow Per Share | 0.21 | -0.32 | -0.69 | -0.13 | 1.02 | -0.12 | Upgrade |
Dividend Per Share | 0.110 | 0.110 | 0.380 | 0.610 | 0.490 | 0.410 | Upgrade |
Dividend Growth | -71.05% | -71.05% | -37.70% | 24.49% | 19.51% | 10.81% | Upgrade |
Gross Margin | 70.13% | 72.41% | 72.69% | 76.69% | 77.40% | 80.59% | Upgrade |
Operating Margin | 0.27% | 4.33% | 9.38% | 15.12% | 15.09% | 25.45% | Upgrade |
Profit Margin | 1.11% | 3.25% | 9.75% | 15.27% | 15.81% | 24.53% | Upgrade |
Free Cash Flow Margin | 2.14% | -2.92% | -5.44% | -0.96% | 9.94% | -2.19% | Upgrade |
EBITDA | 273.32 | 465.45 | 775.49 | 1,124 | 866.92 | 740.23 | Upgrade |
EBITDA Margin | 5.67% | 8.67% | 12.76% | 17.68% | 17.52% | 28.12% | Upgrade |
D&A For EBITDA | 260.23 | 233.1 | 205.31 | 162.69 | 120.46 | 70.19 | Upgrade |
EBIT | 13.08 | 232.36 | 570.18 | 961.48 | 746.46 | 670.05 | Upgrade |
EBIT Margin | 0.27% | 4.33% | 9.38% | 15.12% | 15.09% | 25.45% | Upgrade |
Effective Tax Rate | 13.50% | 21.08% | 16.96% | 15.38% | 12.88% | 15.01% | Upgrade |
Revenue as Reported | 4,821 | 5,371 | 6,076 | 6,359 | 4,948 | 2,633 | Upgrade |
Advertising Expenses | - | 1,377 | 1,790 | 2,051 | 1,583 | 618.8 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.